secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2022-08-26T23:59:59+00:00
Accession:  0001628280-22-023779
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sema4 names Kevin Feeley CFO as interim CFO Richard Miao departs
----------------------------------------------------------------

- Interim CFO Richard Miao leaves Sept 2, 2022; entitled to accrued compensation.
- Kevin Feeley appointed CFO effective Aug 25, 2022; also SVP of Operations and Head of GeneDx.
- Feeley receives $450k base salary, 50% target bonus, and $750k equity grant.
- Company files updated GeneDx combined financials for Q1 2022 and pro forma for H1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000162828022023779/0001628280-22-023779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000162828022023779/smfr-20220825.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-023779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer